Mycobacterial infections in solid organ transplant recipients.
Arslan
H
H
Baskent University Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Ankara, Turkey.
Oner-Eyüboglu
F
F
Kalpaklioglu
F
F
Gürdogan
K
K
Akçay
S
S
Demirag
A
A
Haberal
M
M
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009164:Mycobacterium Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000382:microbiology*; D011718:Pyrazinamide / Q000627:therapeutic use; D012189:Retrospective Studies; D012293:Rifampin / Q000627:therapeutic use; D012424:Rural Population; D012959:Socioeconomic Factors; D013997:Time Factors; D014421:Turkey
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin